Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lowe

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Eye (London, England)|October 14, 2025
Infographic: Landmark trials in Neuro-Ophthalmology -results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertensionGabriele Berman, James L Mitchell, Michael Lowe, et al.
Eye (London, England)|March 30, 2026
Infographic: teprotumumab for the treatment of active thyroid eye diseaseErind Alushaj, Michael Lowe, Susan P Mollan, et al.
The Medical Journal of Australia|February 5, 2008
Vocational career paths of graduate entry medical students at Flinders University: a comparison of rural, remote and tertiary tracksPaul Worley, Anne Martin, David Prideaux, et al.
Ultrasonics|July 25, 2024
Simulation of ultrasound backscatter coefficient measurement using the finite element methodGeorge West, Stewart Haslinger, Jeffrey Bamber, et al.
Eye (London, England)|July 16, 2025
Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure TrialGabriele Berman, Michael Lowe, Georgios Tsermoulas, et al.
The Journal of Headache and Pain|July 22, 2022
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluationMichael Lowe, Lesley Murray, Alok Tyagi, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Eye (London, England)|February 20, 2026
Infographic: Teprotumumab for thyroid-associated ophthalmopathyErind Alushaj, Gabriele Berman, Susan P Mollan, et al.
Nanotechnology|July 9, 2024
Patterning optimization for device realization of patterned GaAsSbN nanowire photodetectorsSean Johnson, Rabin Pokharel, Michael Lowe, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Eye (London, England)|October 14, 2025
Infographic: Landmark trials in Neuro-Ophthalmology -results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertensionGabriele Berman, James L Mitchell, Michael Lowe, et al.
Eye (London, England)|March 30, 2026
Infographic: teprotumumab for the treatment of active thyroid eye diseaseErind Alushaj, Michael Lowe, Susan P Mollan, et al.
The Medical Journal of Australia|February 5, 2008
Vocational career paths of graduate entry medical students at Flinders University: a comparison of rural, remote and tertiary tracksPaul Worley, Anne Martin, David Prideaux, et al.
Ultrasonics|July 25, 2024
Simulation of ultrasound backscatter coefficient measurement using the finite element methodGeorge West, Stewart Haslinger, Jeffrey Bamber, et al.
Eye (London, England)|July 16, 2025
Infographic: Landmark trials in Neuro-Ophthalmology-results of the phase II Idiopathic Intracranial Hypertension Pressure TrialGabriele Berman, Michael Lowe, Georgios Tsermoulas, et al.
The Journal of Headache and Pain|July 22, 2022
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluationMichael Lowe, Lesley Murray, Alok Tyagi, et al.
Eye (London, England)|February 5, 2026
Infographic: Randomized trial of bilateral gene therapy injection for m.11778 G > A MT-ND4 Leber optic neuropathy (REFLECT Trial)Sam Sherratt-Mayhew, Charles Page, Michael Lowe, et al.
Eye (London, England)|September 18, 2025
Infographic: landmark trials in Neuro-Ophthalmology-results of the phase II idiopathic intracranial hypertension drug trialMichael Lowe, Gabriele Berman, Fernando Labella Álvarez, et al.
Eye (London, England)|February 20, 2026
Infographic: Teprotumumab for thyroid-associated ophthalmopathyErind Alushaj, Gabriele Berman, Susan P Mollan, et al.
Nanotechnology|July 9, 2024
Patterning optimization for device realization of patterned GaAsSbN nanowire photodetectorsSean Johnson, Rabin Pokharel, Michael Lowe, et al.
Pageof 9